Topics

Gilteritinib Granted FDA Approval for Adults with Acute Myeloid Leukemia

14:50 EST 28 Nov 2018 | Pharmacy Times

The drug’s application was designated for fast track and priority review, as well as orphan product status.
 

Original Article: Gilteritinib Granted FDA Approval for Adults with Acute Myeloid Leukemia

NEXT ARTICLE

More From BioPortfolio on "Gilteritinib Granted FDA Approval for Adults with Acute Myeloid Leukemia"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...